Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabril Vision Study
NCT01278173Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Dec 2010
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vigabatrin in focal onset impaired awareness seizure, sponsored by Lundbeck. Started Dec 2010; status: completed.
02
Drugs
vigabatrin
03
Conditions
focal onset impaired awareness seizure
Beyond the preview
Go deeper on NCT01278173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278173.